Loading…

mRNA-1273 or mRNA-Omicron boost in vaccinated macaques elicits comparable B cell expansion, neutralizing antibodies and protection against Omicron

SARS-CoV-2 Omicron is highly transmissible and has substantial resistance to antibody neutralization following immunization with ancestral spike-matched vaccines. It is unclear whether boosting with Omicron-specific vaccines would enhance immunity and protection. Here, nonhuman primates that receive...

Full description

Saved in:
Bibliographic Details
Published in:bioRxiv 2022-02
Main Authors: Gagne, Matthew, Moliva, Juan I, Foulds, Kathryn E, Andrew, Shayne F, Flynn, Barbara J, Werner, Anne P, Wagner, Danielle A, I-Ting, Teng, Lin, Bob C, Moore, Christopher, Jean-Baptiste, Nazaire, Carroll, Robin, Foster, Stephanie L, Patel, Mit, Ellis, Madison, Venkata-Viswanadh Edara, Nahara Vargas Maldonado, Minai, Mahnaz, Mccormick, Lauren, Christopher Cole Honeycutt, Nagata, Bianca M, Bock, Kevin W, Dulan, Caitlyn N M, Cordon, Jamilet, Todd, John-Paul M, Mccarthy, Elizabeth, Pessaint, Laurent, Alex Van Ry, Narvaez, Brandon, Valentin, Daniel, Cook, Anthony, Dodson, Alan, Steingrebe, Katelyn, Flebbe, Dillon R, Nurmukhambetova, Saule T, Godbole, Sucheta, Henry, Amy R, Laboune, Farida, Roberts-Torres, Jesmine, Lorang, Cynthia G, Amin, Shivani, Trost, Jessica, Naisan, Mursal, Basappa, Manjula, Willis, Jacquelyn, Wang, Lingshu, Shi, Wei, Doria-Rose, Nicole A, Olia, Adam S, Liu, Cuiping, Harris, Darcy R, Carfi, Andrea, Mascola, John R, Kwong, Peter D, Edwards, Darin K, Andersen, Hanne, Lewis, Mark G, Corbett, Kizzmekia S, Nason, Martha C, Mcdermott, Adrian B, Suthar, Mehul S, Moore, Ian N, Roederer, Mario, Sullivan, Nancy J, Douek, Daniel C, Seder, Robert A
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Request full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c1197-a9e7a800fab25d3089c2e4e77c8c35711d448793c59b0eed9421da680ed8b5883
cites
container_end_page
container_issue
container_start_page
container_title bioRxiv
container_volume
creator Gagne, Matthew
Moliva, Juan I
Foulds, Kathryn E
Andrew, Shayne F
Flynn, Barbara J
Werner, Anne P
Wagner, Danielle A
I-Ting, Teng
Lin, Bob C
Moore, Christopher
Jean-Baptiste, Nazaire
Carroll, Robin
Foster, Stephanie L
Patel, Mit
Ellis, Madison
Venkata-Viswanadh Edara
Nahara Vargas Maldonado
Minai, Mahnaz
Mccormick, Lauren
Christopher Cole Honeycutt
Nagata, Bianca M
Bock, Kevin W
Dulan, Caitlyn N M
Cordon, Jamilet
Todd, John-Paul M
Mccarthy, Elizabeth
Pessaint, Laurent
Alex Van Ry
Narvaez, Brandon
Valentin, Daniel
Cook, Anthony
Dodson, Alan
Steingrebe, Katelyn
Flebbe, Dillon R
Nurmukhambetova, Saule T
Godbole, Sucheta
Henry, Amy R
Laboune, Farida
Roberts-Torres, Jesmine
Lorang, Cynthia G
Amin, Shivani
Trost, Jessica
Naisan, Mursal
Basappa, Manjula
Willis, Jacquelyn
Wang, Lingshu
Shi, Wei
Doria-Rose, Nicole A
Olia, Adam S
Liu, Cuiping
Harris, Darcy R
Carfi, Andrea
Mascola, John R
Kwong, Peter D
Edwards, Darin K
Andersen, Hanne
Lewis, Mark G
Corbett, Kizzmekia S
Nason, Martha C
Mcdermott, Adrian B
Suthar, Mehul S
Moore, Ian N
Roederer, Mario
Sullivan, Nancy J
Douek, Daniel C
Seder, Robert A
description SARS-CoV-2 Omicron is highly transmissible and has substantial resistance to antibody neutralization following immunization with ancestral spike-matched vaccines. It is unclear whether boosting with Omicron-specific vaccines would enhance immunity and protection. Here, nonhuman primates that received mRNA-1273 at weeks 0 and 4 were boosted at week 41 with mRNA-1273 or mRNA-Omicron. Neutralizing antibody titers against D614G were 4760 and 270 reciprocal ID50 at week 6 (peak) and week 41 (pre-boost), respectively, and 320 and 110 for Omicron. Two weeks after boost, titers against D614G and Omicron increased to 5360 and 2980, respectively, for mRNA-1273 and 2670 and 1930 for mRNA-Omicron. Following either boost, 70-80% of spike-specific B cells were cross-reactive against both WA1 and Omicron. Significant and equivalent control of virus replication in lower airways was observed following either boost. Therefore, an Omicron boost may not provide greater immunity or protection compared to a boost with the current mRNA-1273 vaccine. Competing Interest Statement K.S.C. is an inventor on U.S. Patent No. 10,960,070 B2 and International Patent Application No. WO/2018/081318 entitled: Prefusion Coronavirus Spike Proteins and Their Use. K.S.C. is an inventor on U.S. Patent Application No. 62/972,886 entitled: 2019-nCoV Vaccine. L.W., W.S., J.R.M., M.R., N.J.S. and D.C.D are inventors on U.S. Patent Application No. 63/147,419 entitled: Antibodies Targeting the Spike Protein of Coronaviruses. L.P., A.V.R., B.N., D.V., A.C., A.D., K.S., H.A. and M.G.L. are employees of Bioqual. K.S.C, L.W. and W.S. are inventors on multiple U.S. Patent Applications entitled Anti-Coronavirus Antibodies and Methods of Use. A.C. and D.K.E. are employees of Moderna. M.S.S. serves on the scientific board of advisors for Moderna and Ocugen. The other authors declare no competing interests.
doi_str_mv 10.1101/2022.02.03.479037
format article
fullrecord <record><control><sourceid>proquest_COVID</sourceid><recordid>TN_cdi_proquest_journals_2625410118</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2625410118</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1197-a9e7a800fab25d3089c2e4e77c8c35711d448793c59b0eed9421da680ed8b5883</originalsourceid><addsrcrecordid>eNotkN1KxDAQhXvjhaw-gHcD3tqan3aTXK6Lf7C4IHq9TJPZJdImtU1FfAyf2KgLA4eBc-abmaK44KzinPFrwYSoWC5Z1cowqU6L7_75aVVyoSTEEf6abe_tGAO0MU4JfIAPtNYHTOSgR4vvM01Anbc-TWBjP-CIbUdwA5a6DuhzwDD5GK4g0JxG7PyXDwfAkHwbnc9hDA6GMSayKfsAD-hDRh3BZ8XJHruJzo-6KF7vbl_WD-Vme_-4Xm1Ky7lRJRpSqBnbYysaJ5k2VlBNSlltZaM4d3WtlZG2MS0jcqYW3OFSM3K6bbSWi-Lyf25e5femtHuL8xgycieWoqnzx7iWP19xYdw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2625410118</pqid></control><display><type>article</type><title>mRNA-1273 or mRNA-Omicron boost in vaccinated macaques elicits comparable B cell expansion, neutralizing antibodies and protection against Omicron</title><source>Coronavirus Research Database</source><creator>Gagne, Matthew ; Moliva, Juan I ; Foulds, Kathryn E ; Andrew, Shayne F ; Flynn, Barbara J ; Werner, Anne P ; Wagner, Danielle A ; I-Ting, Teng ; Lin, Bob C ; Moore, Christopher ; Jean-Baptiste, Nazaire ; Carroll, Robin ; Foster, Stephanie L ; Patel, Mit ; Ellis, Madison ; Venkata-Viswanadh Edara ; Nahara Vargas Maldonado ; Minai, Mahnaz ; Mccormick, Lauren ; Christopher Cole Honeycutt ; Nagata, Bianca M ; Bock, Kevin W ; Dulan, Caitlyn N M ; Cordon, Jamilet ; Todd, John-Paul M ; Mccarthy, Elizabeth ; Pessaint, Laurent ; Alex Van Ry ; Narvaez, Brandon ; Valentin, Daniel ; Cook, Anthony ; Dodson, Alan ; Steingrebe, Katelyn ; Flebbe, Dillon R ; Nurmukhambetova, Saule T ; Godbole, Sucheta ; Henry, Amy R ; Laboune, Farida ; Roberts-Torres, Jesmine ; Lorang, Cynthia G ; Amin, Shivani ; Trost, Jessica ; Naisan, Mursal ; Basappa, Manjula ; Willis, Jacquelyn ; Wang, Lingshu ; Shi, Wei ; Doria-Rose, Nicole A ; Olia, Adam S ; Liu, Cuiping ; Harris, Darcy R ; Carfi, Andrea ; Mascola, John R ; Kwong, Peter D ; Edwards, Darin K ; Andersen, Hanne ; Lewis, Mark G ; Corbett, Kizzmekia S ; Nason, Martha C ; Mcdermott, Adrian B ; Suthar, Mehul S ; Moore, Ian N ; Roederer, Mario ; Sullivan, Nancy J ; Douek, Daniel C ; Seder, Robert A</creator><creatorcontrib>Gagne, Matthew ; Moliva, Juan I ; Foulds, Kathryn E ; Andrew, Shayne F ; Flynn, Barbara J ; Werner, Anne P ; Wagner, Danielle A ; I-Ting, Teng ; Lin, Bob C ; Moore, Christopher ; Jean-Baptiste, Nazaire ; Carroll, Robin ; Foster, Stephanie L ; Patel, Mit ; Ellis, Madison ; Venkata-Viswanadh Edara ; Nahara Vargas Maldonado ; Minai, Mahnaz ; Mccormick, Lauren ; Christopher Cole Honeycutt ; Nagata, Bianca M ; Bock, Kevin W ; Dulan, Caitlyn N M ; Cordon, Jamilet ; Todd, John-Paul M ; Mccarthy, Elizabeth ; Pessaint, Laurent ; Alex Van Ry ; Narvaez, Brandon ; Valentin, Daniel ; Cook, Anthony ; Dodson, Alan ; Steingrebe, Katelyn ; Flebbe, Dillon R ; Nurmukhambetova, Saule T ; Godbole, Sucheta ; Henry, Amy R ; Laboune, Farida ; Roberts-Torres, Jesmine ; Lorang, Cynthia G ; Amin, Shivani ; Trost, Jessica ; Naisan, Mursal ; Basappa, Manjula ; Willis, Jacquelyn ; Wang, Lingshu ; Shi, Wei ; Doria-Rose, Nicole A ; Olia, Adam S ; Liu, Cuiping ; Harris, Darcy R ; Carfi, Andrea ; Mascola, John R ; Kwong, Peter D ; Edwards, Darin K ; Andersen, Hanne ; Lewis, Mark G ; Corbett, Kizzmekia S ; Nason, Martha C ; Mcdermott, Adrian B ; Suthar, Mehul S ; Moore, Ian N ; Roederer, Mario ; Sullivan, Nancy J ; Douek, Daniel C ; Seder, Robert A</creatorcontrib><description>SARS-CoV-2 Omicron is highly transmissible and has substantial resistance to antibody neutralization following immunization with ancestral spike-matched vaccines. It is unclear whether boosting with Omicron-specific vaccines would enhance immunity and protection. Here, nonhuman primates that received mRNA-1273 at weeks 0 and 4 were boosted at week 41 with mRNA-1273 or mRNA-Omicron. Neutralizing antibody titers against D614G were 4760 and 270 reciprocal ID50 at week 6 (peak) and week 41 (pre-boost), respectively, and 320 and 110 for Omicron. Two weeks after boost, titers against D614G and Omicron increased to 5360 and 2980, respectively, for mRNA-1273 and 2670 and 1930 for mRNA-Omicron. Following either boost, 70-80% of spike-specific B cells were cross-reactive against both WA1 and Omicron. Significant and equivalent control of virus replication in lower airways was observed following either boost. Therefore, an Omicron boost may not provide greater immunity or protection compared to a boost with the current mRNA-1273 vaccine. Competing Interest Statement K.S.C. is an inventor on U.S. Patent No. 10,960,070 B2 and International Patent Application No. WO/2018/081318 entitled: Prefusion Coronavirus Spike Proteins and Their Use. K.S.C. is an inventor on U.S. Patent Application No. 62/972,886 entitled: 2019-nCoV Vaccine. L.W., W.S., J.R.M., M.R., N.J.S. and D.C.D are inventors on U.S. Patent Application No. 63/147,419 entitled: Antibodies Targeting the Spike Protein of Coronaviruses. L.P., A.V.R., B.N., D.V., A.C., A.D., K.S., H.A. and M.G.L. are employees of Bioqual. K.S.C, L.W. and W.S. are inventors on multiple U.S. Patent Applications entitled Anti-Coronavirus Antibodies and Methods of Use. A.C. and D.K.E. are employees of Moderna. M.S.S. serves on the scientific board of advisors for Moderna and Ocugen. The other authors declare no competing interests.</description><identifier>DOI: 10.1101/2022.02.03.479037</identifier><language>eng</language><publisher>Cold Spring Harbor: Cold Spring Harbor Laboratory Press</publisher><subject>Antibodies ; Coronaviruses ; COVID-19 ; Immunization ; Inventors ; Lymphocytes B ; mRNA ; Patent applications ; Severe acute respiratory syndrome coronavirus 2 ; Spike protein ; Vaccines</subject><ispartof>bioRxiv, 2022-02</ispartof><rights>2022. Notwithstanding the ProQuest Terms and conditions, you may use this content in accordance with the associated terms available at https://www.biorxiv.org/content/10.1101/2022.02.03.479037v1</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c1197-a9e7a800fab25d3089c2e4e77c8c35711d448793c59b0eed9421da680ed8b5883</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/2625410118?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>786,790,27958,38551,43930</link.rule.ids><linktorsrc>$$Uhttps://www.proquest.com/docview/2625410118/abstract/?pq-origsite=primo$$EView_record_in_ProQuest$$FView_record_in_$$GProQuest$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Gagne, Matthew</creatorcontrib><creatorcontrib>Moliva, Juan I</creatorcontrib><creatorcontrib>Foulds, Kathryn E</creatorcontrib><creatorcontrib>Andrew, Shayne F</creatorcontrib><creatorcontrib>Flynn, Barbara J</creatorcontrib><creatorcontrib>Werner, Anne P</creatorcontrib><creatorcontrib>Wagner, Danielle A</creatorcontrib><creatorcontrib>I-Ting, Teng</creatorcontrib><creatorcontrib>Lin, Bob C</creatorcontrib><creatorcontrib>Moore, Christopher</creatorcontrib><creatorcontrib>Jean-Baptiste, Nazaire</creatorcontrib><creatorcontrib>Carroll, Robin</creatorcontrib><creatorcontrib>Foster, Stephanie L</creatorcontrib><creatorcontrib>Patel, Mit</creatorcontrib><creatorcontrib>Ellis, Madison</creatorcontrib><creatorcontrib>Venkata-Viswanadh Edara</creatorcontrib><creatorcontrib>Nahara Vargas Maldonado</creatorcontrib><creatorcontrib>Minai, Mahnaz</creatorcontrib><creatorcontrib>Mccormick, Lauren</creatorcontrib><creatorcontrib>Christopher Cole Honeycutt</creatorcontrib><creatorcontrib>Nagata, Bianca M</creatorcontrib><creatorcontrib>Bock, Kevin W</creatorcontrib><creatorcontrib>Dulan, Caitlyn N M</creatorcontrib><creatorcontrib>Cordon, Jamilet</creatorcontrib><creatorcontrib>Todd, John-Paul M</creatorcontrib><creatorcontrib>Mccarthy, Elizabeth</creatorcontrib><creatorcontrib>Pessaint, Laurent</creatorcontrib><creatorcontrib>Alex Van Ry</creatorcontrib><creatorcontrib>Narvaez, Brandon</creatorcontrib><creatorcontrib>Valentin, Daniel</creatorcontrib><creatorcontrib>Cook, Anthony</creatorcontrib><creatorcontrib>Dodson, Alan</creatorcontrib><creatorcontrib>Steingrebe, Katelyn</creatorcontrib><creatorcontrib>Flebbe, Dillon R</creatorcontrib><creatorcontrib>Nurmukhambetova, Saule T</creatorcontrib><creatorcontrib>Godbole, Sucheta</creatorcontrib><creatorcontrib>Henry, Amy R</creatorcontrib><creatorcontrib>Laboune, Farida</creatorcontrib><creatorcontrib>Roberts-Torres, Jesmine</creatorcontrib><creatorcontrib>Lorang, Cynthia G</creatorcontrib><creatorcontrib>Amin, Shivani</creatorcontrib><creatorcontrib>Trost, Jessica</creatorcontrib><creatorcontrib>Naisan, Mursal</creatorcontrib><creatorcontrib>Basappa, Manjula</creatorcontrib><creatorcontrib>Willis, Jacquelyn</creatorcontrib><creatorcontrib>Wang, Lingshu</creatorcontrib><creatorcontrib>Shi, Wei</creatorcontrib><creatorcontrib>Doria-Rose, Nicole A</creatorcontrib><creatorcontrib>Olia, Adam S</creatorcontrib><creatorcontrib>Liu, Cuiping</creatorcontrib><creatorcontrib>Harris, Darcy R</creatorcontrib><creatorcontrib>Carfi, Andrea</creatorcontrib><creatorcontrib>Mascola, John R</creatorcontrib><creatorcontrib>Kwong, Peter D</creatorcontrib><creatorcontrib>Edwards, Darin K</creatorcontrib><creatorcontrib>Andersen, Hanne</creatorcontrib><creatorcontrib>Lewis, Mark G</creatorcontrib><creatorcontrib>Corbett, Kizzmekia S</creatorcontrib><creatorcontrib>Nason, Martha C</creatorcontrib><creatorcontrib>Mcdermott, Adrian B</creatorcontrib><creatorcontrib>Suthar, Mehul S</creatorcontrib><creatorcontrib>Moore, Ian N</creatorcontrib><creatorcontrib>Roederer, Mario</creatorcontrib><creatorcontrib>Sullivan, Nancy J</creatorcontrib><creatorcontrib>Douek, Daniel C</creatorcontrib><creatorcontrib>Seder, Robert A</creatorcontrib><title>mRNA-1273 or mRNA-Omicron boost in vaccinated macaques elicits comparable B cell expansion, neutralizing antibodies and protection against Omicron</title><title>bioRxiv</title><description>SARS-CoV-2 Omicron is highly transmissible and has substantial resistance to antibody neutralization following immunization with ancestral spike-matched vaccines. It is unclear whether boosting with Omicron-specific vaccines would enhance immunity and protection. Here, nonhuman primates that received mRNA-1273 at weeks 0 and 4 were boosted at week 41 with mRNA-1273 or mRNA-Omicron. Neutralizing antibody titers against D614G were 4760 and 270 reciprocal ID50 at week 6 (peak) and week 41 (pre-boost), respectively, and 320 and 110 for Omicron. Two weeks after boost, titers against D614G and Omicron increased to 5360 and 2980, respectively, for mRNA-1273 and 2670 and 1930 for mRNA-Omicron. Following either boost, 70-80% of spike-specific B cells were cross-reactive against both WA1 and Omicron. Significant and equivalent control of virus replication in lower airways was observed following either boost. Therefore, an Omicron boost may not provide greater immunity or protection compared to a boost with the current mRNA-1273 vaccine. Competing Interest Statement K.S.C. is an inventor on U.S. Patent No. 10,960,070 B2 and International Patent Application No. WO/2018/081318 entitled: Prefusion Coronavirus Spike Proteins and Their Use. K.S.C. is an inventor on U.S. Patent Application No. 62/972,886 entitled: 2019-nCoV Vaccine. L.W., W.S., J.R.M., M.R., N.J.S. and D.C.D are inventors on U.S. Patent Application No. 63/147,419 entitled: Antibodies Targeting the Spike Protein of Coronaviruses. L.P., A.V.R., B.N., D.V., A.C., A.D., K.S., H.A. and M.G.L. are employees of Bioqual. K.S.C, L.W. and W.S. are inventors on multiple U.S. Patent Applications entitled Anti-Coronavirus Antibodies and Methods of Use. A.C. and D.K.E. are employees of Moderna. M.S.S. serves on the scientific board of advisors for Moderna and Ocugen. The other authors declare no competing interests.</description><subject>Antibodies</subject><subject>Coronaviruses</subject><subject>COVID-19</subject><subject>Immunization</subject><subject>Inventors</subject><subject>Lymphocytes B</subject><subject>mRNA</subject><subject>Patent applications</subject><subject>Severe acute respiratory syndrome coronavirus 2</subject><subject>Spike protein</subject><subject>Vaccines</subject><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>COVID</sourceid><sourceid>PIMPY</sourceid><recordid>eNotkN1KxDAQhXvjhaw-gHcD3tqan3aTXK6Lf7C4IHq9TJPZJdImtU1FfAyf2KgLA4eBc-abmaK44KzinPFrwYSoWC5Z1cowqU6L7_75aVVyoSTEEf6abe_tGAO0MU4JfIAPtNYHTOSgR4vvM01Anbc-TWBjP-CIbUdwA5a6DuhzwDD5GK4g0JxG7PyXDwfAkHwbnc9hDA6GMSayKfsAD-hDRh3BZ8XJHruJzo-6KF7vbl_WD-Vme_-4Xm1Ky7lRJRpSqBnbYysaJ5k2VlBNSlltZaM4d3WtlZG2MS0jcqYW3OFSM3K6bbSWi-Lyf25e5femtHuL8xgycieWoqnzx7iWP19xYdw</recordid><startdate>20220204</startdate><enddate>20220204</enddate><creator>Gagne, Matthew</creator><creator>Moliva, Juan I</creator><creator>Foulds, Kathryn E</creator><creator>Andrew, Shayne F</creator><creator>Flynn, Barbara J</creator><creator>Werner, Anne P</creator><creator>Wagner, Danielle A</creator><creator>I-Ting, Teng</creator><creator>Lin, Bob C</creator><creator>Moore, Christopher</creator><creator>Jean-Baptiste, Nazaire</creator><creator>Carroll, Robin</creator><creator>Foster, Stephanie L</creator><creator>Patel, Mit</creator><creator>Ellis, Madison</creator><creator>Venkata-Viswanadh Edara</creator><creator>Nahara Vargas Maldonado</creator><creator>Minai, Mahnaz</creator><creator>Mccormick, Lauren</creator><creator>Christopher Cole Honeycutt</creator><creator>Nagata, Bianca M</creator><creator>Bock, Kevin W</creator><creator>Dulan, Caitlyn N M</creator><creator>Cordon, Jamilet</creator><creator>Todd, John-Paul M</creator><creator>Mccarthy, Elizabeth</creator><creator>Pessaint, Laurent</creator><creator>Alex Van Ry</creator><creator>Narvaez, Brandon</creator><creator>Valentin, Daniel</creator><creator>Cook, Anthony</creator><creator>Dodson, Alan</creator><creator>Steingrebe, Katelyn</creator><creator>Flebbe, Dillon R</creator><creator>Nurmukhambetova, Saule T</creator><creator>Godbole, Sucheta</creator><creator>Henry, Amy R</creator><creator>Laboune, Farida</creator><creator>Roberts-Torres, Jesmine</creator><creator>Lorang, Cynthia G</creator><creator>Amin, Shivani</creator><creator>Trost, Jessica</creator><creator>Naisan, Mursal</creator><creator>Basappa, Manjula</creator><creator>Willis, Jacquelyn</creator><creator>Wang, Lingshu</creator><creator>Shi, Wei</creator><creator>Doria-Rose, Nicole A</creator><creator>Olia, Adam S</creator><creator>Liu, Cuiping</creator><creator>Harris, Darcy R</creator><creator>Carfi, Andrea</creator><creator>Mascola, John R</creator><creator>Kwong, Peter D</creator><creator>Edwards, Darin K</creator><creator>Andersen, Hanne</creator><creator>Lewis, Mark G</creator><creator>Corbett, Kizzmekia S</creator><creator>Nason, Martha C</creator><creator>Mcdermott, Adrian B</creator><creator>Suthar, Mehul S</creator><creator>Moore, Ian N</creator><creator>Roederer, Mario</creator><creator>Sullivan, Nancy J</creator><creator>Douek, Daniel C</creator><creator>Seder, Robert A</creator><general>Cold Spring Harbor Laboratory Press</general><scope>8FE</scope><scope>8FH</scope><scope>AAFGM</scope><scope>AAMXL</scope><scope>ABOIG</scope><scope>ABUWG</scope><scope>ADZZV</scope><scope>AFKRA</scope><scope>AFLLJ</scope><scope>AFOLM</scope><scope>AGAJT</scope><scope>AQTIP</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>COVID</scope><scope>DWQXO</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>LK8</scope><scope>M7P</scope><scope>PIMPY</scope><scope>PQCXX</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>20220204</creationdate><title>mRNA-1273 or mRNA-Omicron boost in vaccinated macaques elicits comparable B cell expansion, neutralizing antibodies and protection against Omicron</title><author>Gagne, Matthew ; Moliva, Juan I ; Foulds, Kathryn E ; Andrew, Shayne F ; Flynn, Barbara J ; Werner, Anne P ; Wagner, Danielle A ; I-Ting, Teng ; Lin, Bob C ; Moore, Christopher ; Jean-Baptiste, Nazaire ; Carroll, Robin ; Foster, Stephanie L ; Patel, Mit ; Ellis, Madison ; Venkata-Viswanadh Edara ; Nahara Vargas Maldonado ; Minai, Mahnaz ; Mccormick, Lauren ; Christopher Cole Honeycutt ; Nagata, Bianca M ; Bock, Kevin W ; Dulan, Caitlyn N M ; Cordon, Jamilet ; Todd, John-Paul M ; Mccarthy, Elizabeth ; Pessaint, Laurent ; Alex Van Ry ; Narvaez, Brandon ; Valentin, Daniel ; Cook, Anthony ; Dodson, Alan ; Steingrebe, Katelyn ; Flebbe, Dillon R ; Nurmukhambetova, Saule T ; Godbole, Sucheta ; Henry, Amy R ; Laboune, Farida ; Roberts-Torres, Jesmine ; Lorang, Cynthia G ; Amin, Shivani ; Trost, Jessica ; Naisan, Mursal ; Basappa, Manjula ; Willis, Jacquelyn ; Wang, Lingshu ; Shi, Wei ; Doria-Rose, Nicole A ; Olia, Adam S ; Liu, Cuiping ; Harris, Darcy R ; Carfi, Andrea ; Mascola, John R ; Kwong, Peter D ; Edwards, Darin K ; Andersen, Hanne ; Lewis, Mark G ; Corbett, Kizzmekia S ; Nason, Martha C ; Mcdermott, Adrian B ; Suthar, Mehul S ; Moore, Ian N ; Roederer, Mario ; Sullivan, Nancy J ; Douek, Daniel C ; Seder, Robert A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1197-a9e7a800fab25d3089c2e4e77c8c35711d448793c59b0eed9421da680ed8b5883</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Antibodies</topic><topic>Coronaviruses</topic><topic>COVID-19</topic><topic>Immunization</topic><topic>Inventors</topic><topic>Lymphocytes B</topic><topic>mRNA</topic><topic>Patent applications</topic><topic>Severe acute respiratory syndrome coronavirus 2</topic><topic>Spike protein</topic><topic>Vaccines</topic><toplevel>online_resources</toplevel><creatorcontrib>Gagne, Matthew</creatorcontrib><creatorcontrib>Moliva, Juan I</creatorcontrib><creatorcontrib>Foulds, Kathryn E</creatorcontrib><creatorcontrib>Andrew, Shayne F</creatorcontrib><creatorcontrib>Flynn, Barbara J</creatorcontrib><creatorcontrib>Werner, Anne P</creatorcontrib><creatorcontrib>Wagner, Danielle A</creatorcontrib><creatorcontrib>I-Ting, Teng</creatorcontrib><creatorcontrib>Lin, Bob C</creatorcontrib><creatorcontrib>Moore, Christopher</creatorcontrib><creatorcontrib>Jean-Baptiste, Nazaire</creatorcontrib><creatorcontrib>Carroll, Robin</creatorcontrib><creatorcontrib>Foster, Stephanie L</creatorcontrib><creatorcontrib>Patel, Mit</creatorcontrib><creatorcontrib>Ellis, Madison</creatorcontrib><creatorcontrib>Venkata-Viswanadh Edara</creatorcontrib><creatorcontrib>Nahara Vargas Maldonado</creatorcontrib><creatorcontrib>Minai, Mahnaz</creatorcontrib><creatorcontrib>Mccormick, Lauren</creatorcontrib><creatorcontrib>Christopher Cole Honeycutt</creatorcontrib><creatorcontrib>Nagata, Bianca M</creatorcontrib><creatorcontrib>Bock, Kevin W</creatorcontrib><creatorcontrib>Dulan, Caitlyn N M</creatorcontrib><creatorcontrib>Cordon, Jamilet</creatorcontrib><creatorcontrib>Todd, John-Paul M</creatorcontrib><creatorcontrib>Mccarthy, Elizabeth</creatorcontrib><creatorcontrib>Pessaint, Laurent</creatorcontrib><creatorcontrib>Alex Van Ry</creatorcontrib><creatorcontrib>Narvaez, Brandon</creatorcontrib><creatorcontrib>Valentin, Daniel</creatorcontrib><creatorcontrib>Cook, Anthony</creatorcontrib><creatorcontrib>Dodson, Alan</creatorcontrib><creatorcontrib>Steingrebe, Katelyn</creatorcontrib><creatorcontrib>Flebbe, Dillon R</creatorcontrib><creatorcontrib>Nurmukhambetova, Saule T</creatorcontrib><creatorcontrib>Godbole, Sucheta</creatorcontrib><creatorcontrib>Henry, Amy R</creatorcontrib><creatorcontrib>Laboune, Farida</creatorcontrib><creatorcontrib>Roberts-Torres, Jesmine</creatorcontrib><creatorcontrib>Lorang, Cynthia G</creatorcontrib><creatorcontrib>Amin, Shivani</creatorcontrib><creatorcontrib>Trost, Jessica</creatorcontrib><creatorcontrib>Naisan, Mursal</creatorcontrib><creatorcontrib>Basappa, Manjula</creatorcontrib><creatorcontrib>Willis, Jacquelyn</creatorcontrib><creatorcontrib>Wang, Lingshu</creatorcontrib><creatorcontrib>Shi, Wei</creatorcontrib><creatorcontrib>Doria-Rose, Nicole A</creatorcontrib><creatorcontrib>Olia, Adam S</creatorcontrib><creatorcontrib>Liu, Cuiping</creatorcontrib><creatorcontrib>Harris, Darcy R</creatorcontrib><creatorcontrib>Carfi, Andrea</creatorcontrib><creatorcontrib>Mascola, John R</creatorcontrib><creatorcontrib>Kwong, Peter D</creatorcontrib><creatorcontrib>Edwards, Darin K</creatorcontrib><creatorcontrib>Andersen, Hanne</creatorcontrib><creatorcontrib>Lewis, Mark G</creatorcontrib><creatorcontrib>Corbett, Kizzmekia S</creatorcontrib><creatorcontrib>Nason, Martha C</creatorcontrib><creatorcontrib>Mcdermott, Adrian B</creatorcontrib><creatorcontrib>Suthar, Mehul S</creatorcontrib><creatorcontrib>Moore, Ian N</creatorcontrib><creatorcontrib>Roederer, Mario</creatorcontrib><creatorcontrib>Sullivan, Nancy J</creatorcontrib><creatorcontrib>Douek, Daniel C</creatorcontrib><creatorcontrib>Seder, Robert A</creatorcontrib><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>Coronavirus Research Database</collection><collection>ProQuest Central Korea</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>Biological Sciences</collection><collection>Biological Science Database</collection><collection>ProQuest - Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Gagne, Matthew</au><au>Moliva, Juan I</au><au>Foulds, Kathryn E</au><au>Andrew, Shayne F</au><au>Flynn, Barbara J</au><au>Werner, Anne P</au><au>Wagner, Danielle A</au><au>I-Ting, Teng</au><au>Lin, Bob C</au><au>Moore, Christopher</au><au>Jean-Baptiste, Nazaire</au><au>Carroll, Robin</au><au>Foster, Stephanie L</au><au>Patel, Mit</au><au>Ellis, Madison</au><au>Venkata-Viswanadh Edara</au><au>Nahara Vargas Maldonado</au><au>Minai, Mahnaz</au><au>Mccormick, Lauren</au><au>Christopher Cole Honeycutt</au><au>Nagata, Bianca M</au><au>Bock, Kevin W</au><au>Dulan, Caitlyn N M</au><au>Cordon, Jamilet</au><au>Todd, John-Paul M</au><au>Mccarthy, Elizabeth</au><au>Pessaint, Laurent</au><au>Alex Van Ry</au><au>Narvaez, Brandon</au><au>Valentin, Daniel</au><au>Cook, Anthony</au><au>Dodson, Alan</au><au>Steingrebe, Katelyn</au><au>Flebbe, Dillon R</au><au>Nurmukhambetova, Saule T</au><au>Godbole, Sucheta</au><au>Henry, Amy R</au><au>Laboune, Farida</au><au>Roberts-Torres, Jesmine</au><au>Lorang, Cynthia G</au><au>Amin, Shivani</au><au>Trost, Jessica</au><au>Naisan, Mursal</au><au>Basappa, Manjula</au><au>Willis, Jacquelyn</au><au>Wang, Lingshu</au><au>Shi, Wei</au><au>Doria-Rose, Nicole A</au><au>Olia, Adam S</au><au>Liu, Cuiping</au><au>Harris, Darcy R</au><au>Carfi, Andrea</au><au>Mascola, John R</au><au>Kwong, Peter D</au><au>Edwards, Darin K</au><au>Andersen, Hanne</au><au>Lewis, Mark G</au><au>Corbett, Kizzmekia S</au><au>Nason, Martha C</au><au>Mcdermott, Adrian B</au><au>Suthar, Mehul S</au><au>Moore, Ian N</au><au>Roederer, Mario</au><au>Sullivan, Nancy J</au><au>Douek, Daniel C</au><au>Seder, Robert A</au><format>book</format><genre>document</genre><ristype>GEN</ristype><atitle>mRNA-1273 or mRNA-Omicron boost in vaccinated macaques elicits comparable B cell expansion, neutralizing antibodies and protection against Omicron</atitle><jtitle>bioRxiv</jtitle><date>2022-02-04</date><risdate>2022</risdate><abstract>SARS-CoV-2 Omicron is highly transmissible and has substantial resistance to antibody neutralization following immunization with ancestral spike-matched vaccines. It is unclear whether boosting with Omicron-specific vaccines would enhance immunity and protection. Here, nonhuman primates that received mRNA-1273 at weeks 0 and 4 were boosted at week 41 with mRNA-1273 or mRNA-Omicron. Neutralizing antibody titers against D614G were 4760 and 270 reciprocal ID50 at week 6 (peak) and week 41 (pre-boost), respectively, and 320 and 110 for Omicron. Two weeks after boost, titers against D614G and Omicron increased to 5360 and 2980, respectively, for mRNA-1273 and 2670 and 1930 for mRNA-Omicron. Following either boost, 70-80% of spike-specific B cells were cross-reactive against both WA1 and Omicron. Significant and equivalent control of virus replication in lower airways was observed following either boost. Therefore, an Omicron boost may not provide greater immunity or protection compared to a boost with the current mRNA-1273 vaccine. Competing Interest Statement K.S.C. is an inventor on U.S. Patent No. 10,960,070 B2 and International Patent Application No. WO/2018/081318 entitled: Prefusion Coronavirus Spike Proteins and Their Use. K.S.C. is an inventor on U.S. Patent Application No. 62/972,886 entitled: 2019-nCoV Vaccine. L.W., W.S., J.R.M., M.R., N.J.S. and D.C.D are inventors on U.S. Patent Application No. 63/147,419 entitled: Antibodies Targeting the Spike Protein of Coronaviruses. L.P., A.V.R., B.N., D.V., A.C., A.D., K.S., H.A. and M.G.L. are employees of Bioqual. K.S.C, L.W. and W.S. are inventors on multiple U.S. Patent Applications entitled Anti-Coronavirus Antibodies and Methods of Use. A.C. and D.K.E. are employees of Moderna. M.S.S. serves on the scientific board of advisors for Moderna and Ocugen. The other authors declare no competing interests.</abstract><cop>Cold Spring Harbor</cop><pub>Cold Spring Harbor Laboratory Press</pub><doi>10.1101/2022.02.03.479037</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier DOI: 10.1101/2022.02.03.479037
ispartof bioRxiv, 2022-02
issn
language eng
recordid cdi_proquest_journals_2625410118
source Coronavirus Research Database
subjects Antibodies
Coronaviruses
COVID-19
Immunization
Inventors
Lymphocytes B
mRNA
Patent applications
Severe acute respiratory syndrome coronavirus 2
Spike protein
Vaccines
title mRNA-1273 or mRNA-Omicron boost in vaccinated macaques elicits comparable B cell expansion, neutralizing antibodies and protection against Omicron
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-09-23T05%3A28%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_COVID&rft_val_fmt=info:ofi/fmt:kev:mtx:book&rft.genre=document&rft.atitle=mRNA-1273%20or%20mRNA-Omicron%20boost%20in%20vaccinated%20macaques%20elicits%20comparable%20B%20cell%20expansion,%20neutralizing%20antibodies%20and%20protection%20against%20Omicron&rft.jtitle=bioRxiv&rft.au=Gagne,%20Matthew&rft.date=2022-02-04&rft_id=info:doi/10.1101/2022.02.03.479037&rft_dat=%3Cproquest_COVID%3E2625410118%3C/proquest_COVID%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c1197-a9e7a800fab25d3089c2e4e77c8c35711d448793c59b0eed9421da680ed8b5883%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2625410118&rft_id=info:pmid/&rfr_iscdi=true